HRT Financial’s General Moly, Inc. GMO Stock Holding History

HRT Financial’s Portfolio GMO Stock Details GMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14,906	Closed	-$3K	–	1866
2019 Q3	$3K	Buy	+14,906	New	+$3.72K	﹤0.01%	1366

Other funds holding GMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SIM

Sonora Investment Management Tucson, Arizona $798M AUM 17.61% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HRT Financial's GMO Position: Q4 2019 in Review

HRT Financial sold out of General Moly, Inc. (GMO) in Q4 2019, closing a stake of 14,906 shares — an estimated $3K sold.

HRT Financial first reported a position in GMO in Q3 2019 and held it in 1 quarter. The position peaked at $3K in Q3 2019. 32 funds tracked by Wall St. Rank hold GMO as of Q4 2019.

HRT Financial reported no remaining General Moly, Inc. position as of Q4 2019 after selling out during the quarter.
HRT Financial sold 14,906 General Moly, Inc. shares in Q4 2019, an estimated $3K.
HRT Financial first reported a position in General Moly, Inc. in Q3 2019 and held it in 1 quarter.
HRT Financial's General Moly, Inc. position peaked at $3K in Q3 2019.
32 funds tracked by Wall St. Rank held General Moly, Inc. as of Q4 2019.

Based on HRT Financial's 13F filing for Q4 2019, filed 14 Feb 2020.